Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study.

Shahjada Selim Muhammad Shah Alam Samir Kumar Talukder Md Lutful Kabir Abu Jar Gaffar Md Ahamedul Kabir Nusrat Zarin Shahin Ibn Rahman Md Masud Un Nabi Marufa Mustari Md Firoj Hossain Ahmed Ifrad Bin Raunak Md Azizul Hoque Md Rashedul Islam S M Mahbubur Rashid Mohammad Abdul Hannan Mohammad Saifuddin Md Asaduzzaman Mohammad Motiur Rahman Afsar AhammedMd Abdur RafiMohammad Jahid HasanA B M Kamrul-Hasan

Published in: BMC endocrine disorders (2023)

Though most patients with T2DM achieved their target LDL level, the prevalence of both glycemic and overall lipid control was low in our study despite lipid-lowering therapy.

Keyphrases

fatty acid
type diabetes
clinical trial
stem cells
bone marrow
metabolic syndrome
cell therapy
skeletal muscle